Belimumab for systemic lupus erythematosus

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the benefits and harms of belimumab in systematic lupus erythematosus (SLE).

Ancillary